img
img

Survey

References

  1. World Bank. 1993. World Development Report 1993: Investing in Health. © New York: Oxford University Press. hdl.handle.net/10986/5976 License: CC BY 3.0 IGO.
  2. The Value of Investing in Innovative Medicines: Socioeconomic Burden and Annual  Social Impact of Roche Treatments  for HER2+ Breast Cancer, Multiple  Sclerosis and Retinal Disease, Wifor Institute, 2024, Study URL: www.wifor.com/en/download/the-value-of-investing-in-innovative-medicines-socioeconomic-burden-and-annual-social-impact-of-roche-treatments-for-her2-breast-cancer-multiple-sclerosis-and-retinal-disease/
  3. F. R. Lichtenberg, ‘The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries’, Economics & Human Biology, vol. 46, p. 101124, Aug. 2022, doi: 10.1016/j.ehb.2022.101124.
  4. OECD/European Commission (2024), Health at a Glance: Europe 2024: State of Health in the EU Cycle, OECD Publishing, Paris, doi.org/10.1787/b3704e14-en, Figure 5.3. Health expenditure as a share of GDP, 2022 (or nearest year)